Literature DB >> 24924513

Robotic intracorporeal urinary diversion: technical details to improve time efficiency.

Mihir M Desai1, Andre Luis Castro de Abreu, Alvin C Goh, Adrian Fairey, Andre Berger, Scott Leslie, Hui Wen Xie, Karanvir S Gill, Gus Miranda, Monish Aron, Rene J Sotelo, Yinghao Sun, Zhang Xu, Inderbir Singh Gill.   

Abstract

OBJECTIVES: To present time-efficiency data during our initial experience with intracorporeal urinary diversion and technical tips that may shorten operative time early in the learning curve. PATIENTS AND METHODS: Data were analyzed in the initial 37 consecutive patients undergoing robotic radical cystectomy and intracorporeal urinary diversion in whom detailed stepwise operative time data were available. Median age was 65 years and median body mass index was 27. Neoadjuvant chemotherapy was administered in 6 patients and 11 patients had clinical evidence of T3 or lymph node-positive disease. Each component of the operation was subdivided into specific steps and operative time for each step was prospectively recorded. Peri-operative and follow-up data up to 90 days and final pathological data were recorded.
RESULTS: All procedures were completed intracorporeally and robotically without need for conversion to open surgery or extracorporeal diversion. Median total operative time was 387 vs 386 minutes (p=0.2) and median total console time was 361 vs 295 minutes (p<0.007) for orthotopic neobladder and ileal conduit, respectively. Median time for radical cystectomy was 77 minutes, extended pelvic lymph node dissection was 63 minutes, and diversion was 111 minutes (ileal conduit 92 minutes and orthotopic neobladder 124 minutes). Median estimated blood loss was 250 mL, and median hospital stay was 9 days. High grade (Clavien grade 3-5) complications at 30 and 90 days follow-up were recorded in 6 (16%) and 9 (24%) patients, respectively. Over a median follow-up of 16 months, 12 (32%) patients experienced disease recurrence and 9 (24%) died from bladder cancer. These correspond to 1-year recurrence-free and overall survival of 64% and 70%, respectively.
CONCLUSIONS: Intracorporeal urinary diversion following robotic radical cystectomy can be safely performed and reproducible in a time-efficient manner even during the early learning curve.

Entities:  

Mesh:

Year:  2014        PMID: 24924513     DOI: 10.1089/end.2014.0284

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  11 in total

1.  Robotic assisted laparoscopic radical cystectomy with stentless intracorporeal modified Ves.Pa neobladder: early experience.

Authors:  Patrick Whelan; Wei Phin Tan; Dimitri Papagiannopoulos; Philip Omotosho; Leslie Deane
Journal:  J Robot Surg       Date:  2017-01-09

Review 2.  Current Status of Robot-Assisted Radical Cystectomy and Intracorporeal Urinary Diversion.

Authors:  Raj Kurpad; Michael Woods; Raj Pruthi
Journal:  Curr Urol Rep       Date:  2016-06       Impact factor: 3.092

Review 3.  Updates on Robotic Intracorporeal Urinary Diversions.

Authors:  Shawn Dason; Alvin C Goh
Journal:  Curr Urol Rep       Date:  2018-03-15       Impact factor: 3.092

Review 4.  Robot-assisted laparoscopic radical cystectomy with complete intracorporeal urinary diversion.

Authors:  Jason M Sandberg; Ashok K Hemal
Journal:  Asian J Urol       Date:  2016-05-27

5.  Laparoscopic radical cystectomy with intracorporeal ileal conduit: one center experience and clinical outcomes.

Authors:  Jianye Li; Feiya Yang; Qingbao He; Mingshuai Wang; Nianzeng Xing
Journal:  Int Braz J Urol       Date:  2019 May-Jun       Impact factor: 1.541

Review 6.  Totally intracorporeal robot-assisted urinary diversion for bladder cancer (part 2). Review and detailed characterization of the existing intracorporeal orthotopic ileal neobladder.

Authors:  Hugo Otaola-Arca; Kulthe Ramesh Seetharam Bhat; Vipul R Patel; Marcio Covas Moschovas; Marcelo Orvieto
Journal:  Asian J Urol       Date:  2020-06-08

Review 7.  Contemporary techniques and outcomes of robotic assisted radical cystectomy with intracorporeal urinary diversion.

Authors:  Ardenne S Martin; Anthony T Corcoran
Journal:  Transl Androl Urol       Date:  2021-05

Review 8.  Contemporary evidence for robot-assisted radical cystectomy for treating bladder cancer.

Authors:  Raj Satkunasivam; Christopher J D Wallis; Robert K Nam; Mihir Desai; Inderbir S Gill
Journal:  Nat Rev Urol       Date:  2016-08-09       Impact factor: 16.430

9.  Safe transition from extracorporeal to intracorporeal urinary diversion following robot-assisted cystectomy: a recipe for reducing operative time, blood loss and complication rates.

Authors:  Teck Wei Tan; Rajesh Nair; Sanad Saad; Ramesh Thurairaja; Muhammad Shamim Khan
Journal:  World J Urol       Date:  2018-06-22       Impact factor: 4.226

10.  Do patients benefit from total intracorporeal robotic radical cystectomy?: A comparative analysis with extracorporeal robotic radical cystectomy from a Korean multicenter study.

Authors:  Ji Sung Shim; Tae Gyun Kwon; Koon Ho Rha; Young Goo Lee; Ji Youl Lee; Byong Chang Jeong; Jong Hyun Pyun; Sung Gu Kang; Seok Ho Kang
Journal:  Investig Clin Urol       Date:  2019-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.